Parasite | Eso | Sto | Cancer | ESD
1. ³ëÀÎ ³»°úÇÐ (°¡Å縯ÀÇ´ë Àü´ë¼ö)
Àü´ë¼ö ±³¼ö´ÔÀº ³ëÀÎÀÌ ¾àÇØÁö´Â ¿øÀÎÀÇ Çϳª·Î ¿µ¾ç ºÎÁ·, ƯÈ÷ ´Ü¹éÁú ºÎÁ·À» °Á¶ÇÏ¿´½À´Ï´Ù. ÇѸ¶µð·Î °í±â¸¦ ÀÚÁÖ ¸¹ÀÌ ¸ÔÀ¸¶ó´Â À̾߱⿴½À´Ï´Ù.
¾à¹°À» ÁÖÀÇÇØ¾ß ÇÕ´Ï´Ù.
NSAIDs´Â analgesic dose¿Í anti-inflammatory dose°¡ ´Ù¸¨´Ï´Ù.
Analgesics (OA) | Anti-inflammatory (RA) | |
Meloxicam | 7.5 mg qd | 7.5 mg bid or 15 mg qd |
Naproxen | 500 mg qd | 500 mg bid |
Ibuprofen | 400 mg tid | 800 mg tid |
Celecoxib | 100 mg bid or 200 mg qd | 200 mg bid |
Acetaminophen
Vitamin D supplement (USPSTF recommendation, JAMA 2018;319:1599) | |
Prevention of falls at high rish >= 65 years | Not recommended |
Primary prevention of fracture >= 50 years (Men and premenopausal women) | Insufficient evidence |
Primary prevention of fracture >= 50 years (Postmenopausal women) | <= 400 IU, not recommended > 400 IU, insufficient evidence |
2. ¾ß¿Ü È°µ¿¿¡¼ ¸¸³¯ ¼ö ÀÖ´Â °¨¿°¼º ¿¼ºÁúȯ (°¡Ãµ´ëÇб³ ±æº´¿ø °¨¿°³»°ú ¾öÁß½Ä)
2018³âÀº ¿©·¯ ¿¼ºÁúȯÀÌ ÁÙ¾ú½À´Ï´Ù. ¿ÃÇØ ¿©¸§ÀÌ ±Ø½ÉÇÏ°Ô ´õ¿ü±â ¶§¹®¿¡ ¸ð±â³ª Áøµå±â µîÀÇ »ýÈ°»ç°¡ ÆíÇÏ¿´±â ¶§¹®ÀÌ ¾Æ´Ñ°¡ ÃßÁ¤µË´Ï´Ù.
1) SFTS (ÁßÁõ¿¼ºÇ÷¼ÒÆÇ°¨¼ÒÁõ)
ö»õ¿¡ ÀÇÇØ ÂüÁøµå±â°¡ ¿ì¸®³ª¶ó·Î ¿Å°Ü¿Â °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.
ÂüÁøµå±â¿¡ ÀÇÇØ ¹°¸° ÀÚ±¹¿¡ Áøµå±â°¡ ¹ÚÇô ÀÖ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù. ¼ÕÀ¸·Î Á¦°ÅÇÏ´Â µµÁß Áøµå±â°¡ ºñƲ¾îÁö°Å³ª, ȸÀüÇÏ¿© ºÎ¼ÅÁö°Å³ª, ¿ÏÀüÈ÷ ºüÁöÁö ¾ÊÀ¸¸é viral load°¡ Áõ°¡ÇϹǷΠÀ§ÇèÇÕ´Ï´Ù. ÇɼÂÀ¸·Î 90µµ·Î µé¾î¿Ã¸®´Â ¹æ¹ýÀ¸·Î Á¦°ÅÇØ¾ß ÇÕ´Ï´Ù.
2) ÂêÂê°¡¹«½Ãº´
Ãæûµµ À̳² Áö¿ªÀº º¸·É Ç÷ûÇüÀÌ ¸¹°í less toxic ÇÕ´Ï´Ù. °¿øµµ¿¡¼´Â Gilliam Ç÷ûÇüÀÌ ¸¹Àºµ¥ more toxic ÇÕ´Ï´Ù.
¹ã³ª¹«¿¡ ÅÐÁøµå±â°¡ ¸¹½À´Ï´Ù. ¹ãÀ» µþ ¶§ °¨¿°µÇ±âµµ ÇÕ´Ï´Ù.
±Ø½ÉÇÑ µÎÅë°ú ±ÙÀ°Åë, Eschar, ¹ßÁø, ±¹¼Ò.
3ÀÏ ÀÌ»ó ¿ÀÌ ³ª°í, 3¹ø ÀÌ»ó ¿ÀÌ ³ª°í, ±âħ/°¡·¡/Ä๰ÀÌ ¾øÀ¸¸é °¨±â¸ö»ìÀÌ ¾Æ´Ï¶ó ´Ù¸¥ ÁúȯÀ» ÀǽÉÇØ¾ß ÇÕ´Ï´Ù.
¾ÆÁÖ Ãʱ⿡´Â serology°¡ À½¼ºÀ¸·Î ³ª¿Ã ¼ö ÀÖÀ¸¹Ç·Î eschar¸¸À¸·Î Áø´ÜÇÒ ¼ö ÀÖ½À´Ï´Ù.
[2018-11-24. ÀÌÁØÇà Áú¹®]
ÇÑ Áý´ãȸ¿¡¼ °æ³²Áö¿ª ȯÀÚÀε¥ eschar¶ó°í »ý°¢ÇÏ¿´´ø º´¼Ò°¡ ÀÖ¾ú´Âµ¥ Ç÷¾×°Ë»ç¿¡¼ SFTS·Î Áø´ÜµÈ ȯÀÚ¸¦ º» ÀûÀÌ ÀÖ½À´Ï´Ù. ÂüÁøµå±â¿¡ ÀÇÇÑ ¹°¸° ÀÚ±¹°ú scrub typhusÀÇ eschar¸¦ ±¸º°ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀº? ÂüÁøµå±â(tick)¿¡ ÀÇÇÑ SFTS¿Í ÅÐÁøµå±â(mite)¿¡ ÀÇÇÑ scrub typhusÀÇ º¹ÇÕ°¨¿°¿¹´Â ¾ø´ÂÁö¿ä? Ç÷û°Ë»çÀÇ cross-reactivity´Â ¾øÀ»±î¿ä?
[2018-11-24. ¾öÁᫎ ±³¼ö´Ô ´äº¯]
Eschar·Î º¸À̴µ¥¿ä, scrub typhus°¡ °è¼Ó À½¼ºÀ̾ú´Ù¸é murine typhus µî¿¡ ´ëÇÑ Ç÷û°Ë»çµµ ÇØ º¸´Â °ÍÀÌ ÁÁ°Ú½À´Ï´Ù. µ¿½Ã°¨¿°Àº ÀÌ·Ð»ó °¡´ÉÇÏ°ÚÁö¸¸ ¸Å¿ì µå¹® »óȲÀÏ °Í °°½À´Ï´Ù. Á¤È®ÇÑ ÀÚ·á´Â ¾Ë ¼ö ¾øÀ¸³ª SFTS´Â ¹ÙÀÌ·¯½º ÁúȯÀÌ°í, scrub typhus´Â ¸®ÄÏÂ÷ ÁúȯÀ̹ǷΠ°Ë»çÀÇ cross-reactvity´Â ³·À» °Í °°½À´Ï´Ù. SFTS´Â RT-PCR·Î Áø´ÜÇÕ´Ï´Ù.
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.